Correlation between clinical features, morphology, and immunophenotype in ALCL
| Clinical form of ALCL . | Morphology . | Phenotype . | EMA . | Chimeric ALK . |
|---|---|---|---|---|
| Systemic | All variants | Mostly T/null | Frequently positive | Positive (∼ 60%) |
| Primary cutaneous | Common type to lymphomatoid papulosis | T/null | Some | Negative3-150 |
| HIV-related | Common or giant cell–rich | Mostly B | NDA | NDA |
| Rarely T/null | NDA | NDA | ||
| Secondary | Variable | T/null3-151 | Negative | Negative |
| Clinical form of ALCL . | Morphology . | Phenotype . | EMA . | Chimeric ALK . |
|---|---|---|---|---|
| Systemic | All variants | Mostly T/null | Frequently positive | Positive (∼ 60%) |
| Primary cutaneous | Common type to lymphomatoid papulosis | T/null | Some | Negative3-150 |
| HIV-related | Common or giant cell–rich | Mostly B | NDA | NDA |
| Rarely T/null | NDA | NDA | ||
| Secondary | Variable | T/null3-151 | Negative | Negative |